Odyssey Therapeutics, Inc.
Research Odyssey Therapeutics, Inc. (ODTX) on Bullrun: market cap USD 1.26B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerODTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.26B
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 52.79M
- Free cash flow-USD 34.69M
Valuation Snapshot
latest market cap is USD 1.26B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.26B | n/a | n/a | n/a |
About Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5);
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Odyssey Therapeutics, Inc.'s market cap?
Odyssey Therapeutics, Inc.'s market capitalization is USD 1.26B.
What does Odyssey Therapeutics, Inc. do?
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.